Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas
Abstract Human soft-tissue sarcomas (STS) are rare mesenchymal tumors with a 5-year survival rate of 50%, highlighting the need for further STS research. Research has been hampered by limited human sarcoma cell line availability and the large number of STS subtypes, making development of STS cell li...
Guardado en:
Autores principales: | Kyle M. Schachtschneider, Yingkai Liu, Suvi Mäkeläinen, Ole Madsen, Laurie A. Rund, Martien A. M. Groenen, Lawrence B. Schook |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7314ba9aa5ac4be891d578f92f1235cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel P, et al.
Publicado: (2012) -
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Eve Merry, et al.
Publicado: (2021) -
Sarcoma
Publicado: (1997) -
Targeting glutamine metabolism slows soft tissue sarcoma growth
por: Pearl Lee, et al.
Publicado: (2020) -
Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
por: Jin Yuan MD, et al.
Publicado: (2021)